City

Jacksonville (1)

Omaha (1)

Rochester (1)

Scottsdale (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Mayo Clinic (1)

University of Nebraska (1)

Collaborator

National Cancer Institute (NCI) (2)

Adherex Technologies, Inc. (1)

Intervention

cisplatin (2)

gemcitabine hydrochloride (2)

laboratory biomarker analysis (2)

adh-1 (1)

pharmacological study (1)

ricolinostat (1)

Study Documents

Intervention Type

drug (2)

other (2)

Funder Type

Other (2)

Study Type

Interventional (2)

stage iiia hilar cholangiocarcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ampulla of Vater Adenocarcinoma, Gallbladder Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Omaha (ADH-1,

Completed

Ampulla of Vater Adenocarcinoma
+19 more

ADH-1
+3 more

Omaha, Nebraska

University of Nebraska Medical Center

Jan 26, 2018

Non-Resectable Cholangiocarcinoma, Recurrent Cholangiocarcinoma, Stage III Extrahepatic Bile Duct Cancer Trial in Scottsdale,

Withdrawn

Non-Resectable Cholangiocarcinoma
+12 more

Cisplatin
+4 more

Scottsdale, Arizona
+2 more

May 25, 2017